QurAlis
Barry F. has extensive work experience in quality assurance and compliance in the biotech and pharmaceutical industry. Barry has held various leadership positions, including Vice President of Quality Assurance at QurAlis, where they developed and implemented GxP strategies and ensured regulatory compliance. Barry also worked as an independent quality assurance consultant, focusing on start-up to mid-sized biotech companies. Barry has experience in GLP and GCP auditing, inspection readiness, and operational oversight. Barry has worked for companies such as CytomX Therapeutics, Agios Pharmaceuticals, Mapp Biopharmaceutical Inc, Covance Central Laboratory Services SA, Lilly, MPI Research, and Wyeth Pharmaceuticals, where they served in roles such as Senior Director, Director, Senior Manager, and Clinical Manager/Monitor.
Barry F. attended Knox College from 1992 to 1996, although the degree obtained and field of study remain unspecified. Additionally, Barry F. has obtained certifications in RQAP-GLP and RQAP-GCP from the Society of Quality Assurance. The specific month and year of these certifications are unknown.
This person is not in any offices
QurAlis
1 followers
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.